Literature DB >> 8927476

[Interferon alpha in the treatment of polycythemia vera in a 13-year-old girl].

M Ołpiński1, T Jakieła, R Korczowski.   

Abstract

The authors present a rare case of polycythemia vera (PV) in a 13-year-old girl initially treated with phlebotomy only and then also with interferon alpha at a dose of 3 x 10(6) U three times per week subcutaneously. The treatment outcome measure was the reduction of the number of phlebotomies required to retain a normal hematocrit value. Treatment with interferon enabled a substantial reduction of phlebotomies and caused a decrease in platelet count. These results confirm that interferon alpha may be regarded as a promising therapeutic approach in the management of PV.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8927476

Source DB:  PubMed          Journal:  Pediatr Pol        ISSN: 0031-3939


  2 in total

1.  Ruxolitinib treatment in an infant with JAK2+ polycythaemia vera-associated Budd-Chiari syndrome.

Authors:  Mehmet Enes Coskun; Sue Height; Anil Dhawan; Nedim Hadzic
Journal:  BMJ Case Rep       Date:  2017-07-14

Review 2.  Clinical and hematological presentation of children and adolescents with polycythemia vera.

Authors:  Holger Cario; Mary Frances McMullin; Heike L Pahl
Journal:  Ann Hematol       Date:  2009-05-26       Impact factor: 3.673

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.